BioCopy BioCopy BioCopy BioCopy
  • Home
  • Technology
  • Applications
  • Company
  • Investors
  • Career
  • Contact
  • German
BioCopy BioCopy
  • Home
  • Technology
  • Applications
  • Company
  • Investors
  • Career
  • Contact
  • German

“Spin-offs To Watch 2021”: Forbes selects BioCopy as one of the 30 particularly most promising spin-offs in the DACH region

[minti_button link="https://biocopy.ch/wp-content/uploads/2021/02/Forbes_Spin-offs-to-watch-2021.pdf" target="_blank"... read more →
  • 22. February 2021

Conference on the European healthcare industry in the Covid-19 crisis

BioCopy and CureVac present their contribution to the Covid-19 pandemic to representatives of the European Parliament and the European Commission at a virtual conference held by the... read more →
  • 4. December 2020

Swiss start-up BioCopy revolutionizes vaccine development

  • 20. November 2020

Functions like a photocopier

The St. Galler Tagblatt addresses the corona pandemic and clearly shows where there are still gaps in pandemic control and defence, but also reveals who can help find... read more →
  • 14. November 2020

BISKUIT: A funded project by the state of Baden-Württemberg, Germany, for rapid identification of COVID19 resistances

  • 25. September 2020

SARS-Cov2 pandemic: Biocopy characterizes binding sites of neutralizing antibodies

In recent weeks, the BioCopy team has been working hard and applying BioCopy technology to help fight the global Sars Cov2 pandemic. The first promising partial results from a... read more →
  • 19. June 2020

First COVID-19 arrays from BioCopy

As predicted by BioCopy in spring 2019, the current development of vaccines is too slow for the spread of a novel virus. COVID-19, respectively its pathogen Sars-Cov2, shows us... read more →
  • 1. May 2020

Second successful investor symposium in Zurich

A few weeks after the first occurrence of the previously unknown corona virus (nCoV-2019), BioCopy held its 2nd Investors’ Symposium in Zurich on 23 January 2020. Around 50 interested... read more →
  • 23. January 2020

Acquisition of Biametrics GmbH

In mid-January 2020, BioCopy Holding AG was able to acquire the entire assets and patent portfolio of Biametrics GmbH. We have been working together with Biametrics GmbH for more... read more →
  • 15. January 2020

BioCopy Holding AG

Navigation

Home
Technology
Company
Investors
Contact

Contact

BioCopy Holding AG
Industriestrasse 15
CH-8355 Aadorf

+41 52 245 04 40
info@biocopy.ch

Imprint
Privacy Policy

© 2019 BioCopy Holding AG

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.

Allow all cookiesPrivacy policy